Is Noble Midstream Partners a good dividend stock?

Noble Midstream Partners (NYSE:NBLX) pays an annual dividend of $0.75 per share and currently has a dividend yield of 4.93%. NBLX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.

What other stocks do shareholders of Noble Midstream Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Noble Midstream Partners investors own include AT&T (T) , Enterprise Products Partners (EPD) , Energy Transfer (ET) , Pfizer (PFE) , Cisco Systems (CSCO) , Intel (INTC) , ONEOK (OKE) , Verizon Communications (VZ) and AbbVie (ABBV) .

When did Noble Midstream Partners IPO?

Noble Midstream Partners (NBLX) raised $250 million in an IPO on Thursday, September 15th 2016. The company issued 12,500,000 shares at a price of $19.00-$21.00 per share. Barclays, Baird, J.P. Morgan, BofA Merrill Lynch, Citigroup, Deutsche Bank Securities, DNB Markets, Mizuho Securities, MUFG and Wells Fargo Securities served as the underwriters for the IPO and BB&T Capital Markets, BNP PARIBAS, CIBC Fifth Third Securities, PNC Capital Markets, Scotia Howard Weil, SOCIETE GENERALE, SMBC Nikko and TD Securities were co-managers.

NYSE:NBLX

Noble Midstream Partners (NBLX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free NBLX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $15.21
▼
$15.21
50-Day Range: $15.21
▼
$15.21
52-Week Range: $5.62
▼
$15.73

Volume: N/A
Average Volume: 883,457 shs
Market Capitalization: $1.37 billion

P/E Ratio: N/A
Dividend Yield: 4.93%
Price Target: N/A

Stock Analysis

Get Noble Midstream Partners alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

NBLX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive NBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Noble Midstream Partners and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Transportation and Warehousing
Industry: Pipeline Transportation Of Crude Oil
Sub-Industry: N/A
Current Symbol: NYSE:NBLX
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 90,347,000
Free Float: N/A
Market Cap: $1.37 billion
Optionable: Not Optionable
Beta: N/A

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

NBLX Stock Analysis - Frequently Asked Questions

Is Noble Midstream Partners a good dividend stock?: Noble Midstream Partners (NYSE:NBLX) pays an annual dividend of $0.75 per share and currently has a dividend yield of 4.93%. NBLX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
What other stocks do shareholders of Noble Midstream Partners own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Noble Midstream Partners investors own include AT&T (T), Enterprise Products Partners (EPD), Energy Transfer (ET), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), ONEOK (OKE), Verizon Communications (VZ) and AbbVie (ABBV).
When did Noble Midstream Partners IPO?: Noble Midstream Partners (NBLX) raised $250 million in an IPO on Thursday, September 15th 2016. The company issued 12,500,000 shares at a price of $19.00-$21.00 per share. Barclays, Baird, J.P. Morgan, BofA Merrill Lynch, Citigroup, Deutsche Bank Securities, DNB Markets, Mizuho Securities, MUFG and Wells Fargo Securities served as the underwriters for the IPO and BB&T Capital Markets, BNP PARIBAS, CIBC Fifth Third Securities, PNC Capital Markets, Scotia Howard Weil, SOCIETE GENERALE, SMBC Nikko and TD Securities were co-managers.

This page (NYSE:NBLX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Noble Midstream Partners (NBLX) Stock Price, News & Analysis

NBLX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

NBLX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info